BillionToOne (BLLN) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.36
- Estimate
- $0.16
- Surprise
- +124.3%
- Revenue (period 2026-06-30)
- $109.4M
- Score at report (before → after)
- 5.6 → 5.5/10
Revenue source: xbrl.
How the report landed
BillionToOne (BLLN) beat the $0.16 estimate with adjusted EPS of $0.36 — a large 124.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.6/10) to Hold at 5.5/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates BLLN Buy (Wait) at 6.1/10.
2 of the last 3 quarters beat the estimate; this quarter's +124.3% surprise compares with a +194.2% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Positive news sentiment (+1.00)
What argues against it
- Concentration risk — Customer: third-party payors
- Expensive valuation
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $99.94
- Entry target
- $95.31
- Price target
- $112.23
- Stop
- $92.36
- Upside to target
- +12.3%
- Reward-to-risk
- 0.8:1
The stock trades at 158.6× trailing but 67.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
BLLN at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $4.72B
- P/E (fwd)
- 67.3
- P/E (ttm)
- 158.6
- 52-week range
- $61.96–$150.44
- Off 52-week high
- 33.6%
- RSI (14)
- 47
- Volume vs avg
- 1.70×
- Score today
- 6.1/10